3 Matching Annotations
  1. Last 7 days
    1. NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma

      [Paper-level Aggregated] PMCID: PMC12221223

      Evidence Type(s): Oncogenic, Predictive

      Justification: Oncogenic: The text describes C>T transitions as characteristic of UV-induced mutations in melanoma, which are well-established features of cutaneous melanoma, indicating a role in tumorigenesis. Predictive: The identification of specific mutations, such as C>T transitions, suggests potential pharmacological targets for treatment in NF1Mut melanomas, indicating a predictive aspect for therapeutic response.

      Gene→Variant (gene-first): NF1(4763):C>T

      Genes: NF1(4763)

      Variants: C>T

    2. To identify molecules that could be pharmacologically targeted in NF1Mut melanomas, we first established 32 STCs from subcutaneous, lymph node, and brain metastases of 30 patients with melanoma (Fig. 1A; Supplementary Ta

      [Paragraph-level] PMCID: PMC12221223 Section: RESULTS PassageIndex: 3

      Evidence Type(s): Diagnostic, Oncogenic

      Justification: Diagnostic: The passage discusses the identification of mutational profiles in melanoma, specifically mentioning that C>T transitions are characterized as cutaneous melanoma-defining features, which indicates a role in classifying or defining the disease. Oncogenic: The mention of C>T transitions as part of the mutational profile in melanoma suggests that these somatic variants contribute to tumor development or progression, particularly in the context of melanoma.

      Gene→Variant (gene-first): 4763:C>T

      Genes: 4763

      Variants: C>T

    3. To identify molecules that could be pharmacologically targeted in NF1Mut melanomas, we first established 32 STCs from subcutaneous, lymph node, and brain metastases of 30 patients with melanoma (Fig. 1A; Supplementary Ta

      [Paragraph-level] PMCID: PMC12221223 Section: RESULTS PassageIndex: 3

      Evidence Type(s): Diagnostic, Oncogenic

      Justification: Diagnostic: The passage discusses the identification of mutational profiles in melanoma, specifically mentioning that C>T transitions are characterized as cutaneous melanoma-defining features, which indicates a role in classifying or defining the disease. Oncogenic: The mention of C>T transitions as part of the mutational profile in melanoma suggests that these somatic variants contribute to tumor development or progression, particularly in the context of melanoma.

      Gene→Variant (gene-first): 4763:C>T

      Genes: 4763

      Variants: C>T